Department of Health and Human Services September 30, 2008 – Federal Register Recent Federal Regulation Documents

Agency Information Collection Request; 60-Day Public Comment Request
Document Number: E8-22976
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services
Notice of Meeting; National Commission on Children and Disasters
Document Number: E8-22939
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, Administration for Children and Families, Children and Families Administration
Pursuant to Public Law 92-463, the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the First Meeting of the National Commission on Children and Disasters, Department of Health and Human Services. The meeting will be held from approximately 8:30 a.m. to 5 p.m. on Tuesday, October 14, 2008, at the Administration for Children and Families, 370 L'Enfant Promenade, SW., Washington, DC. The meeting will be open to the public; however, seating is limited and pre-registration is encouraged (see below).
National Cancer Institute; Notice of Closed Meetings
Document Number: E8-22921
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
Antiviral Drugs Advisory Committee; Notice of Meeting
Document Number: E8-22912
Type: Notice
Date: 2008-09-30
Agency: Food and Drug Administration, Department of Health and Human Services
Medical Device User Fee and Modernization Act; Notice to Public of Web Location of 2009 Proposed Guidance Development
Document Number: E8-22911
Type: Notice
Date: 2008-09-30
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the Web location where the agency will post a list of guidance documents the Center for Devices and Radiological Health (CDRH) is considering for development in fiscal year (FY) 2009. In addition, FDA has established a docket where stakeholders may provide comments and/or draft language for those topics as well as suggestions for new or different guidances.
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
Document Number: E8-22896
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
Document Number: E8-22895
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting
Document Number: E8-22894
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
Prospective Grant of an Exclusive License: Therapeutics Based on Histone Deacetylase (HDAC) Inhibitors for the Prevention and Treatment of Central Nervous System (CNS) Metastases of Extra-CNS Origin Cancers
Document Number: E8-22893
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
This notice, in accordance with 35 U.S.C. 209(c)(1) and 37 CFR Part 404.7(a)(1)(i), announces that the Department of Health and Human Services is contemplating the grant of an exclusive license to practice the inventions embodied in U.S. Provisional Application 60/891,856 filed February 27, 2007 (E-084-2007/0-US-01) and International Application PCT/US2008/055149 filed February 27, 2008 (E-084-2007/0- PCT-02), entitled ``Use of Histone Deacetylase Inhibitors for the Treatment of Central Nervous System Metastases,'' to Waypharm S.A.S. The patent rights in these inventions have been assigned to the United States of America. The prospective exclusive license territory may be the United States and Europe, and the field of use may be limited to therapeutics based on CNS metastases of extra-CNS origin cancers.
National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings
Document Number: E8-22892
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
Government-Owned Inventions; Availability for Licensing
Document Number: E8-22889
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, National Institutes of Health
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing in the U.S. in accordance with 35 U.S.C. 207 to achieve expeditious commercialization of results of federally funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Notice of Meeting of the Advisory Committee on Organ Transplantation
Document Number: E8-22821
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, Health Resources and Services Administration
Pursuant to Public Law 92-463, the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the fourteenth meeting of the Advisory Committee on Organ Transplantation (ACOT), Department of Health and Human Services (HHS). The meeting will be held from approximately 8:30 a.m. to 5 p.m. on November 13, 2008, and from 8:30 a.m. to 3 p.m. on November 14, 2008, at the Hilton Washington DC/Rockville Executive Meeting Center, 1750 Rockville Pike, Rockville, MD 20852. The meeting will be open to the public; however, seating is limited and pre-registration is encouraged (see below).
OIG Supplemental Compliance Program Guidance for Nursing Facilities
Document Number: E8-22796
Type: Notice
Date: 2008-09-30
Agency: Department of Health and Human Services, Office of Inspector General, Inspector General Office, Health and Human Services Department, Centers for Medicare & Medicaid Services
This Federal Register notice sets forth the supplemental compliance program guidance (CPG) for nursing facilities developed by the Office of Inspector General (OIG). OIG is supplementing its prior CPG for nursing facilities issued in 2000. The supplemental CPG contains new compliance recommendations and an expanded discussion of risk areas. The supplemental CPG takes into account Medicare and Medicaid nursing facility payment systems and regulations, evolving industry practices, current enforcement priorities (including the Government's heightened focus on quality of care), and lessons learned in the area of nursing facility compliance. The supplemental CPG provides voluntary guidelines to assist nursing facilities in identifying significant risk areas and in evaluating and, as necessary, refining ongoing compliance efforts.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.